2015 annual financial data
Capricor Therapeutics 2015 Operating margin
Direct answer
Operating margin was -334%.
Operating income was -12,611,826 USD and net income was -12,857,339 USD.
Operating cash flow was -10,817,286 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,776,041 USD
- Operating income
- -12,611,826 USD
- Net income
- -12,857,339 USD
- Operating cash flow
- -10,817,286 USD